OpportunityTitle: Strengthening Guyana&apos;s Regional Support Network through Partnership with the Caribbean Public Health Agency (CARPHA) under the President&apos;s Emergency Plan for AIDS Relief
AdditionalInformationOnEligibility: Eligible applicants that can apply for this FOA are listed below: The Caribbean Public Health Agency (CARPHA)
Description: 1. CDC Project Description a. Approach: Activities Outcomes Short Term Outcomes (1-2 Years) Intermediate Outcomes (3-4 Years) Long Term Outcomes (5+ Years) Conduct public health assessment of NPHRL management and operations (M&amp;O) Identify gaps in service delivery Develop human resources (HR) training plan for M&amp;O Develop a remediation plan for quality improvement Develop new Standard Operating Procedures (SOPs) or update existing ones to include contingency plans for human resources (HR) and supply shortages Increased availability and awareness, at all levels of NPHRL, of new or revised SOPS, gaps in service delivery, HR training plan, and the quality improvement remediation plan Increased knowledge and skills of relevant staff on updated M&amp;O protocols and procedures Increased utilization, by NPHRL, of (1) new SOPs and contingency plans for HR and supply shortages, and (2) HR training plan for M&amp;O Reduced gaps in laboratory service delivery Increased and improved oversight, from relevant trained NPHRL staff, on M&amp;O activities Increased adherence to (1) the quality improvement remediation plan, (2) SOPs, and (3) HR training and contingency plans Improved laboratory performance and service quality Reduced supply shortages (related to SOPs) Reduced HR staffing shortages (due to contingency plans) Provide regimented technical assistance (TA) to lab leadership in management and operations (M&amp;O) Recruit and develop a network of qualified lab leaders to train mid-level staff in lab M&amp;O Increased representation of qualified lab leaders in training positions Improved training opportunities and courses available to mid-level staff Increased awareness and utilization of M&amp;O skills amongst mid-level staff Increased task-shifting from lab leaders to trained mid-level staff Improved laboratory performance and service quality Improved coordination amongst lab personnel of lab service delivery Reduced delays in sample processing and delivery of results due to improved management Develop a single quality assurance (QA) assessment tool for service delivery sites in collaboration with MOH Implement a pilot QA evaluation using the newly developed tool (4 intervention sites and 2 control sites) Determine feasibility of quality assessment tool Establish baseline quality measures for 6 evaluation sites Assess impact of tool and accompanying QA program in improving service quality Increased awareness and utilization of the single QA assessment tool over other tools Reduced need for parallel programs implemented by different agencies Increased documentations of deficiencies in service quality at the site level as a result of tool utilization Increased efficiency in measuring quality due to the single assessment tool Increased awareness and use of evaluation findings for program improvement at intervention sites Improved quality assurance programming at the site and national level Increased availability of strategic information around service quality by site Coordinate provider trainings in the clinical engagement and management of key populations (KP) at high risk from HIV infection and secondary transmission** Increased awareness and utilization, among providers, of HIV best practices in keeping with PEPFAR strategies and international HIV care recommendations Increased contact between providers from government clinical facility and civil society organizations and NGOs Increased awareness of operational strategies for clinical management of HIV-infected members of key populations Increased collaborative care provision between national clinical treatment centers and civil society care and support organizations Increased access to quality HIV clinical care by KPs Improved linkage to, and retention in care, especially for key populations Increased leadership, by clinical staff, of a sustainable, country-led response to the HIV/AIDS epidemic in Guyana Detail the level of adherence/compliance of MOH program managers and senior staff to key population program implementation requirements Identify operational gaps in key populations&#8217; program delivery (stock-outs of materials, difficulty recruiting and retaining providers, inability to reach targeting populations using recommended strategy, etc.) Collaborate with the MOH to conduct a key populations end-user assessment Identify barriers to access and uptake of clinical services by HIV-infected members of key populations Describe preferred service delivery options as reported by HIV-infected key populations (e.g. hours of operation, location, attending clinical staff type, clinical service gaps) Develop new and revised key populations&#8217; programming guidance addressing operational and uptake challenges identified by administrators and end-users Develop provider training agenda for KPs Improved awareness among MOH program managers and senior staff of KP program implementation requirements (including operational gaps) Increased understanding, at all levels, of the barriers to access and uptake of clinical services by KPs Increased adoption of recommendations (based on end-user queries) to amend current KP service delivery model Increased utilization of revised KP programming guidance at the facility level Improved coverage of services to KPs Reduced gaps in, and challenges to, service delivery to KPs Increased utilization of provider training agenda based on self-reported needs of HIV-infected key populations Increased access and improved uptake of HIV clinical services by key populations Increased HIV positive KPs on ART Increased linkage into care Increased retention in care Reduced disparities between the general and key populations in HIV transmission and clinical outcomes Perform surveillance capacity assessment for addition of risk and patient monitoring information; include recommendations for increased security and confidentiality Develop a surveillance expansion plan with pilot and implementation timelines Identify required inputs to improve depth, confidentiality and security of surveillance data Increased uptake and utilization of recommendations from surveillance capacity assessment Increased uptake and utilization of surveillance expansion plans Increased confidentiality of surveillance data Improved reliability of surveillance data due to security and confidentiality measures Increased access to and use of routinely captured monitoring data from the surveillance system as a result of expansion plans Increased integration of site-level risk and patient monitoring data into the national surveillance program Increased utilization of surveillance data for program evaluation, reporting and planning Collaborate with the MOH to prepare a national treatment cascade Improve program management by highlighting areas of need across the continuum of care Provide a single program evaluation tool for assessment across the continuum of care Increased awareness at all levels of the need for improved management of a national treatment cascade Increased adoption, at facility-level, of (1) the MOH-driven national treatment cascade (2) program evaluation tool for assessment across the continuum of care Increased awareness and utilization, at facility level, of the program evaluation tool Increased adherence to requirements from the national treatment cascade Increased coverage of target populations on ART Increased retention in care Increased understanding of gaps in treatment delivery across the continuum of care as highlighted through evaluation findings Increased utilization of evaluation findings for program quality improvement Improved program quality across the continuum of care especially in areas identified through use of evaluation findings Reduced HIV-related morbidity and mortality Reduced new transmission of HIV
GrantorContactEmailDescription: Grants Policy
GrantorContactText: Valerie Naglich&lt;br/&gt;EOA5@cdc.gov&lt;br/&gt;
CloseDateExplanation: Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.